Alaska Permanent Fund Corp Agios Pharmaceuticals, Inc. Transaction History

Alaska Permanent Fund Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	$17.06 - $31.42 $762,582 - $1.4 Million	-44,700 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$52.06 - $61.27 $2.33 Million - $2.74 Million	44,700 New	44,700 $2.46 Million

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

Stay updated on Alaska Permanent Fund Corp with notifications on news.